Author

Amanda JoEllen Sloan

Observed name: Amanda J. Sloan

Institution: Orbis Health Solutions (United States)

Observed institution: Orbis Health Solutions (United States)

OpenAlex ID: A5010585383

Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high‐risk melanoma patients: A subgroup analysis

2021 · Robert C. Chick, Mark B. Faries, et al. · Cancer Medicine · 12

Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

2021 · Alexandra M. Adams, Robert C. Chick, et al. · Melanoma Research · 4

Works count: 2

Citation count: 16

H-index: 2

I10-index: 1